Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus-Associated Gastric Adenocarcinoma With ERBB2 Amplification

JCO Precis Oncol. 2021 Nov:5:370-377. doi: 10.1200/PO.20.00272.

¹ Institut Curie, PSL Research University, Department of Medical Oncology, Paris, France.
² Institut Curie, PSL Research University, INSERM U830, Cancer, Heterogeneity, Instability and Plasticity (CHIP), Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France.
³ Institut Curie, PSL Research University, Department of Pathology, Paris, France.
⁴ Institut Mutualiste Montsouris, Department of Pathology, Paris, France.
⁵ Institut Curie, PSL Research University, Department of Genetics, Paris, France.
⁶ Institut Mutualiste Montsouris, Department of Medical Oncology, Paris, France.
⁷ Institut Curie, PSL Research University, Department of Radiology, Paris, France.
⁸ Institut Curie, UVSQ and Paris Saclay University, Saint Cloud, France.

No abstract available

Publication types